- $455.45m
- $464.79m
- $233.80m
Cerus rises on American Red Cross contract for blood system
Brief: Cerus Reports Multi-Year Contract for INTERCEPT Blood System for Platelets with American Red Cross
U.S. RESEARCH ROUNDUP-Avanos Medical, Kraft Heinz, NetApp
Cerus Corp reports results for the quarter ended in December - Earnings Summary
Cerus Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: Cerus Corporation Announces Record Preliminary Q4, FY2021 Product Revenue
Brief: Cerus Corp - On Dec 21, 2021, Co Entered Into Second Amendment To Supply And Manufacturing Agreement With Porex Corporation
Brief: Cerus Corp Raises Full-Year Product Revenue Guidance
Cerus Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: Cerus Corp Announces CMS Issuance Of P-Codes For Hospital Outpatient Billing Of Intercept-Based Therapeutic Products
U.S. STOCKS ON THE MOVE-Zymergen, Robinhood, Tellurian, Alteryx
Brief: Cerus Corporation Announces Appointment Of Ann Lucena To Board Of Directors
U.S. STOCKS ON THE MOVE-Robinhood, Paycom Software, Melco Resorts, Chembio
Cerus jumps on raising annual product guidance, Q2 revenue beat
Cerus Corp reports results for the quarter ended in June - Earnings Summary
Brief: Cerus Raises Full Year Product Revenue Guidance
Brief: Cerus Corp Announces CMS Has Granted New Technology Add-On Payment For Intercept Fibrinogen Complex
Cerus Corp expected to post a loss of 9 cents a share - Earnings Preview
Brief: Cerus Announces Collaboration With Lifesouth Community Blood Centers To Manufacture Intercept Fibrinogen Complex